Walmart to Open Three New Clinical Trial Centers in 2027
The retail chain will expand its research footprint to support medical trials for cardiovascular and Alzheimer’s disease.
Updated on Oct. 27, 2026 in Healthcare
Live Poll
Would you participate in clinical trials held at a retail pharmacy or grocery store?
Walmart and Care Access will open three new clinical trial centers in the first half of 2027, expanding their partnership to bring medical research into retail environments. These sites will provide health screenings and support Phase 2, 3, and 4 trials for conditions such as cardiovascular and Alzheimer’s disease.
Why it matters
The collaboration aims to increase participation in clinical research by moving trials from specialized academic facilities to accessible, high-traffic retail locations. For healthcare operators, this strategy signals a continued shift toward decentralized medical research that leverages existing consumer touchpoints.
Walmart and Care Access operate four existing clinical trial centers, with three additional sites planned for 2027. This growth expands their combined network to seven total facilities across the United States.
The players
Walmart
A global retail corporation operating thousands of big-box stores and grocery locations that increasingly integrate health services.
Care Access
A clinical research organization that develops decentralized infrastructure to conduct trials outside of traditional hospital settings.
The details
The partnership uses infrastructure and technology from Care Access to embed medical research operations directly into existing retail footprints. These centers facilitate patient engagement through one-on-one health consultations and biomarker blood testing. By utilizing retail space for Phase 2, 3, and 4 trials, the companies reduce the barrier to entry for study participation, targeting specific patient populations in community settings.
Timeline
First half of 2027: Three new clinical trial centers will open.
Market Landscape
This move aligns with the industry-wide shift toward decentralized clinical trials, which seek to solve recruitment challenges by moving research closer to patients. It follows a growing pattern of major retailers leveraging physical store networks to capture health services market share.
Healthcare operators and local clinics should monitor whether retail-based research sites affect patient recruitment for their own traditional trial pipelines. The model emphasizes that convenience-based accessibility is becoming a competitive factor in trial enrollment.
The takeaway
This expansion proves that retail locations are increasingly viewed as viable infrastructure for high-level clinical research. Operators should evaluate whether their existing health services footprint can be adapted to support similar research-based revenue streams.
What happens next
The rollout of the new centers is scheduled for the first half of 2027.
Further reading
For broader insight into the sector, see Healthcare.
Source note: This article includes information reported by Drug Store News.
Live Poll
Would you participate in clinical trials held at a retail pharmacy or grocery store?
